Behcet's syndrome --- The summary --- Behcet's syndrome is a debilitating disorder that affects the whole body, usually occurring in young adults. Typically, there may be mouth ulcers, genital ulcers, arthritic joint problems, vision disturbance, and other inflammatory-type symptoms. Since this is a recurrent problem for which we have no cure, we use steroids to control the severity of flare-ups, while maybe chronically using a low-dose steroid to reduce frequency. Other anti-inflammatory and immune-altering drugs can be useful, since lesions often becomes steroid-resistant. Like many other auto-immune/inflammatory disorders (of which arthritis is one of the most well-known), there may be some genetic (familial) tendency. --- The technical stuff --- This is a systemic inflammatory condition, typically affecting mucous membranes and vascular tissues, but also affecting the central nervous system and joints. There is a proposed viral aetiology with many immunological features, often associated with HLA-B5 (human leukocytic antigen). The epidemiology suggests that it occurs in young adults, more often occurring in Japan and the Mediterranean, and twice as likely in men as in women. Typical findings are: - recurrent oral ulcerations (aphthous type) - genital ulcerations - skin lesions - erythema nodosum - subcutaneous thrombophlebitis - epididymitis - gastrointestinal lesions - synovitis and other arthritic symptoms - meningoencephalitis - ocular lesions - acute recurrent anterior and posterior uveitis and vitritis - may become chronic - vaso-occlusive manifestations (peripheral necrotising retinal vasculitis leading to haemorrages and infarction) - retinitis - periphlebitis - aneurysms - late stage changes - secondary retinal neovascularisation - rubeosis iridis - glaucoma - cataract - retinal detachment - optic atrophy Treatment is used to control the severity of the condition, although nothing is curative at present. Steroids are a first line of attack, both orally and topically, but lesions often become steroid resistant after the syndrome becomes chronic. Antimetabolites like chlorambucil and immunosuppressants like cyclosporin are also used to control the immune reaction. Plasma exchange is also an option. The course is often unrelenting, with poor visual prognosis, especially with posterior segment involvement. Visual assessment should be carried out on a 6 monthly basis. Last edited: 24 October 1999